creatine has been researched along with Pyrexia in 10 studies
Excerpt | Relevance | Reference |
---|---|---|
"Nine infants and young children with osteogenesis imperfecta (age range 1-35 months) were treated with intravenous pamidronate." | 9.11 | Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta. ( DiMeglio, LA; Ford, L; McClintock, C; Peacock, M, 2004) |
"Hundred consecutive neutropenic patients with hematological malignancies and persistent fever after 72 h of first-line antibiotic therapy (91% piperacillin/tazobactam) were treated with teicoplanin (800 mg on day 1, then 400 mg/day)+piperacillin/tazobactam+gentamicin from 08/96 to 09/00 (group T) or with vancomycin (2 g/day)+meropenem+levofloxacin from 10/00 to 04/02 (group V)." | 7.74 | An audit of efficacy and toxicity of teicoplanin versus vancomycin in febrile neutropenia: is the different toxicity profile clinically relevant? ( Arns, A; Glasmacher, A; Hahn-Ast, C; Marklein, G; Mühling, A; Orlopp, K; Von Lilienfeld-Toal, M, 2008) |
"Nine infants and young children with osteogenesis imperfecta (age range 1-35 months) were treated with intravenous pamidronate." | 5.11 | Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta. ( DiMeglio, LA; Ford, L; McClintock, C; Peacock, M, 2004) |
"Hundred consecutive neutropenic patients with hematological malignancies and persistent fever after 72 h of first-line antibiotic therapy (91% piperacillin/tazobactam) were treated with teicoplanin (800 mg on day 1, then 400 mg/day)+piperacillin/tazobactam+gentamicin from 08/96 to 09/00 (group T) or with vancomycin (2 g/day)+meropenem+levofloxacin from 10/00 to 04/02 (group V)." | 3.74 | An audit of efficacy and toxicity of teicoplanin versus vancomycin in febrile neutropenia: is the different toxicity profile clinically relevant? ( Arns, A; Glasmacher, A; Hahn-Ast, C; Marklein, G; Mühling, A; Orlopp, K; Von Lilienfeld-Toal, M, 2008) |
"In conclusion, both leukocytosis and renal failure are useful predictors, although timing of measurement is important." | 1.38 | Renal failure and leukocytosis are predictors of a complicated course of Clostridium difficile infection if measured on day of diagnosis. ( Bauer, MP; Dale, AP; Fawley, WN; Gerding, DN; Gorbach, SL; Hensgens, MP; Kuijper, EJ; Miller, MA; Wilcox, MH, 2012) |
"Thirty patients who had gastric varices with gastrorenal or gastrocaval collaterals underwent balloon-occluded retrograde transvenous obliteration." | 1.29 | Balloon-occluded retrograde transvenous obliteration for gastric varices with gastrorenal or gastrocaval collaterals. ( Koito, K; Morita, K; Nagakawa, T; Namieno, T, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (10.00) | 18.7374 |
1990's | 2 (20.00) | 18.2507 |
2000's | 5 (50.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Güneş, A | 1 |
Fidan, S | 1 |
Dulkadir, R | 1 |
Ünlü, E | 1 |
Bauer, MP | 1 |
Hensgens, MP | 1 |
Miller, MA | 1 |
Gerding, DN | 1 |
Wilcox, MH | 1 |
Dale, AP | 1 |
Fawley, WN | 1 |
Kuijper, EJ | 1 |
Gorbach, SL | 1 |
Svenmarker, S | 1 |
Häggmark, S | 1 |
Jansson, E | 1 |
Lindholm, R | 1 |
Appelblad, M | 1 |
Sandström, E | 1 |
Aberg, T | 1 |
CONSTANTSAS, NS | 1 |
DANELATOU-ATHANASSIADOU, C | 1 |
Wu, J | 1 |
Takeo, T | 1 |
Wakui, M | 1 |
Ellsworth, K | 1 |
Fisher, RS | 1 |
DiMeglio, LA | 1 |
Ford, L | 1 |
McClintock, C | 1 |
Peacock, M | 1 |
Trenschel, R | 1 |
Ditschkowski, M | 1 |
Elmaagacli, AH | 1 |
Koldehoff, M | 1 |
Ottinger, H | 1 |
Steckel, N | 1 |
Hlinka, M | 1 |
Peceny, R | 1 |
Rath, PM | 1 |
Dermoumi, H | 1 |
Beelen, DW | 1 |
Hahn-Ast, C | 1 |
Glasmacher, A | 1 |
Arns, A | 1 |
Mühling, A | 1 |
Orlopp, K | 1 |
Marklein, G | 1 |
Von Lilienfeld-Toal, M | 1 |
Koito, K | 1 |
Namieno, T | 1 |
Nagakawa, T | 1 |
Morita, K | 1 |
Rolando, N | 1 |
Harvey, F | 1 |
Brahm, J | 1 |
Philpott-Howard, J | 1 |
Alexander, G | 1 |
Casewell, M | 1 |
Fagan, E | 1 |
Williams, R | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation[NCT02074631] | Phase 2 | 80 participants (Actual) | Interventional | 2015-02-28 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 trials available for creatine and Pyrexia
Article | Year |
---|---|
Use of heparin-bonded circuits in cardiopulmonary bypass improves clinical outcome.
Topics: Aged; Analysis of Variance; Blood Cell Count; Body Temperature; Cardiopulmonary Bypass; Coated Mater | 2002 |
Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta.
Topics: Alkaline Phosphatase; Amino Acids; Anti-Inflammatory Agents; Bone Density; Calcium; Child, Preschool | 2004 |
8 other studies available for creatine and Pyrexia
Article | Year |
---|---|
Evaluation of risk factors associated with first episode febrile seizure.
Topics: Alkaline Phosphatase; Blood Glucose; Child; Child, Preschool; Chlorine; Creatine; Creatine Kinase; F | 2021 |
Renal failure and leukocytosis are predictors of a complicated course of Clostridium difficile infection if measured on day of diagnosis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Confidence | 2012 |
EXCRETION OF AMINO ACIDS IN CHILDHOOD. A RELIABLE METHOD FOR THE DETERMINATION OF AMINO ACID NITROGEN IN URINE.
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Amino Acids; Ammonia; Body Fluids; Child; Collagen | 1964 |
Intracellular energy failure does not underlie hyperthermic spreading depressions in immature rat hippocampal slice.
Topics: Animals; Animals, Newborn; Cortical Spreading Depression; Creatine; Energy Metabolism; Fever; Hippoc | 2003 |
Caspofungin as second-line therapy for fever of unknown origin or invasive fungal infection following allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Antifungal Agents; C-Reactive Protein; Caspofungin; Creatine; Drug Evaluation; Dr | 2005 |
An audit of efficacy and toxicity of teicoplanin versus vancomycin in febrile neutropenia: is the different toxicity profile clinically relevant?
Topics: Anti-Bacterial Agents; Creatine; Drug Therapy, Combination; Female; Fever; Fever of Unknown Origin; | 2008 |
Balloon-occluded retrograde transvenous obliteration for gastric varices with gastrorenal or gastrocaval collaterals.
Topics: Ammonia; Bilirubin; Blood Urea Nitrogen; Catheterization; Collateral Circulation; Contrast Media; Cr | 1996 |
Fungal infection: a common, unrecognised complication of acute liver failure.
Topics: Acute Disease; Acute Kidney Injury; Adolescent; Adult; Autopsy; Candida; Child; Creatine; Female; Fe | 1991 |